LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Clinical trial NCT01856478 · COMPLETED
Trial details
- NCT number
- NCT01856478
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-07
- Primary completion
- 2018-08-22
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.